Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot randomized double-blind trial of single versus double matrix fentanyl patches in chronic cancer pain
2015-000944-41Phase 4Completed
- Sponsor
- Fondazione IRCCS - Istituto Nazionale dei Tumori di Milano
- Start
- Nov 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of fentanyl in cancer pain (2 arms), sponsored by Fondazione IRCCS - Istituto Nazionale dei Tumori di Milano. Primary endpoint: Feasibility of randomized double-blind superiority study. Started Nov 2020; status: completed.
02
Drugs
fentanyl
03
Conditions
cancer pain
Beyond the preview
Go deeper on 2015-000944-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-000944-41.